Biologix Enters into Merger with Advanced Health Institute of Technology

Strategic Insights -

Biologix President and Board of Directors have announced a strategic merger with Advanced Health Institute of Technology, a New York-based organization. This arrangement signals a significant shift in Biologix's direction and may lead to enhanced sales, earnings, and growth in shareholder value. The merged entity will gain access to a substantial infusion of capital and a diverse portfolio of medical companies. Donald J. Shea, CEO of Advanced Health Institute of Technology, will lead the new enterprise and cites the potential for Biologix to play a crucial public venture capital and management assistance role for emerging growth medical firms.

Key Takeaways:

  • Biologix has entered into a full-scale merger with Advanced Health Institute of Technology, a New York-based organization, through a Letter of Intent.
  • The merger represents a significant shift in Biologix's strategic direction, offering potential for increased sales, earnings, and growth in shareholder value.
  • The merged entity will receive a significant infusion of capital for commercialization of Biologix's hand-held point-of-care diagnostic product-line and a roll-in of Advanced Health Institute of Technology's portfolio of medical companies.
  • Donald J. Shea, former Clairol President and Bristol-Myers Squibb senior executive, will serve as CEO of the new enterprise.
  • Advanced Health Institute of Technology was founded to provide financing resources and management expertise for emerging growth companies in the medical, dental, medical devices, and biotechnology industries.
  • The organization has assembled a Scientific Advisory Board consisting of five prominent members of the U.S. medical establishment.

Statistics:

  • Industry sources estimate the worldwide in vitro blood analysis market will reach $14 billion in 1995.
  • Biologix introduced the concept of a hand-held blood gas analyzer in 1988, positioning itself to compete as a low-cost producer in the emerging point-of-care diagnostic market.

Sources:

  • BUSINESS WIRE, "BIOLOGIX and ADVANCED HEALTH INSTITUTE OF TECHNOLOGY Announce Merger Plans", July 26, 1995.
  • BUSINESS WIRE, "BIOLOGIX and ADVANCED HEALTH INSTITUTE OF TECHNOLOGY Announce Merger Plans", July 26, 1995.